Complimentary shipping on US orders over $250
Retatrutide research vial
98.6% HPLC In stock
Metabolic

Retatrutide

LY3437943

Triple-receptor agonist peptide · Lyophilized powder · 10 mg

Research use only — for in-vitro laboratory research. Not for human or veterinary consumption.
$80per 10 mg vial
Size
1
98.6% HPLC verified COA included Same-day US dispatch Discreet, tracked
View certificate of analysisCurrent lot HLT-RETA-2605B
Analytical data

Specifications, verified

Reported from the current lot's certificate of analysis. One purity number, one source — the same figure everywhere it appears.

CompoundRetatrutide
AliasLY3437943
ClassTriple-receptor agonist peptide
FormatLyophilized powder
AppearanceWhite to off-white lyophilized powder
Purity (HPLC)98.6%
Identity (LC-MS)Confirmed
Residual moisture2.1% (Karl Fischer)
Endotoxin< 0.5 EU/mg
SolubilityBacteriostatic water (reconstitution)
StorageStore lyophilized at −20°C, protected from light
Testing labFreedom Diagnostics (independent, US)
Current lotHLT-RETA-2605B
Test date2026-05-24

On this compound

Retatrutide (LY3437943) is a triple-receptor agonist peptide, supplied as a lyophilized powder for in-vitro laboratory research. Helithea describes this material by identity only. This page provides no dosing, administration, protocol, or usage guidance, and makes no claim of any physiological effect. Handling and storage information is provided for laboratory reference.

For laboratory and research use only. Not for human or veterinary use, ingestion, or administration. Not evaluated by the FDA. Sold to qualified researchers (21+) who assume responsibility for lawful handling. No dosing, medical, or usage guidance is provided.